What is Harmony Biosciences Holdings, Inc.'s net change in cash?

Harmony Biosciences Holdings, Inc. (HRMY) reported net change in cash of -$163.1M in Q1 2026.

How has Harmony Biosciences Holdings, Inc.'s net change in cash changed year-over-year?

Harmony Biosciences Holdings, Inc.'s net change in cash decreased by 553.1% year-over-year, from $36M to -$163.1M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Harmony Biosciences Holdings, Inc. HRMY Net Change in Cash

Net Change in Cash at other companies

Jazz PharmaceuticalsJAZZ

$452.4M+182%

AlkermesALKS

-$768.23M-807%

Axsome TherapeuticsAXSM

-$17.83M-23.4%

Stoke Therapeutics, Inc.STOK

$74.44M-49.3%

Amneal Pharmaceuticals, Inc.AMRX

-$108.53M-117%

Acadia PharmaceuticalsACAD

$104.52M+203%

Other financials

Income statement

See full

Revenue$215.4M+16.6%

Gross profit$170.9M+11.9%

Operating income$37.3M-33.7%

Net income$32.5M-28.7%

EPS (diluted)$0.55-29.5%

Balance sheet

See full

Cash & equivalents$589.4M+20.5%

Total debt$164.6M-7.2%

Total equity$910.3M+26.3%

Total assets$1.3B+20.5%

Cash flow

See full

Operating cash flow$27.8M-18.3%

CapEx$107.0K-79.1%

Free cash flow$126.0M+67.9%

Valuation

See full

Market cap$1.98B-14.9%

Enterprise value$1.55B-24.9%

P/E13.6×-1.6×

P/S2.2×-0.9×

Profitability

See full

Gross margin76.5%-1.8pp

Operating margin21.1%-5.1pp

Net margin16.2%-4.3pp

FCF margin40.1%+9.5pp

Returns & leverage

See full

Return on equity17.9%-6.9pp

Debt / equity0.2×-0.1×

Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s net change in cash?: Harmony Biosciences Holdings, Inc. (HRMY) reported net change in cash of -$163.1M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s net change in cash changed year-over-year?: Harmony Biosciences Holdings, Inc.'s net change in cash decreased by 553.1% year-over-year, from $36M to -$163.1M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.